HRT, does new evidence in the BMJ make a difference?
Guest blog post by CEBM Director Dr Carl HeneghanLast week, the 9th of October, the BMJ published research on the ‘Effect of hormone replacement therapy on cardiovascular events in recently...
View ArticlePrice hiking of medicines: mischievous and misaligned
Guest blog post by CEBM Director Dr Carl HeneghanIn reading a print version of a journal, like you do, my eyes wandered to an advert for a new antibiotic for C difficile, ‘to help release your patients...
View ArticleData, data, everywhere?
Hidden data, missing data, withholding data- whatever you call it, not all clinical trial data is publicly available, and we think that’s an issue. Regardless of the description, incomplete data is an...
View ArticleLife line screening versus Dr McCartney: who is right?
Guest blog post by CEBM Director Dr Carl HeneghanLife line report that Dr. McCartney mentions that she believes that carotid artery screening is only worthwhile once the person has already had a...
View ArticleEuropean Medicines Agency commits to proactively publish clinical trial data
The European Medicines Agency (EMA) is committed to the publication of trial data. The question is how to do it? Today, the EMA held a stakeholder workshop which followed the Agency’s decision to...
View ArticleQuality of descriptions of treatments in randomised controlled trials
Analysis of treatment descriptions, published in BMJ Open, shows that for over half (57%) of the papers we reviewed, published treatment descriptions were not considered sufficient to allow...
View ArticleAll Trials Registered | All Results Reported
“Thousands of clinical trials have not reported their results; some have not even been registered.” All trials registered | All results reportedThis is a problem.read more
View ArticleStockpiling in the dark: Tamiflu and the Public Health Agency of Canada
The Government of Canada reported last week that they are working with pharmaceutical manufacturer Roche to release the neuraminidase inhibitor Tamiflu (oseltamivir) from Canadian stockpiles to ensure...
View ArticleForcing the spring towards a new era in evidence-based medicine
“But, by the words we speak and the faces we show the world, we force the spring.”The beginning of Bill Clinton’s first inaugural address seems an odd place to start a discussion about epidemiology, I...
View ArticleThanks to everyone who participated in Evidence Live 2013!
First of all: thank you to everyone who came to Evidence Live 2013 and made it such a success. A conference like this only happens because people come from around the world, taking time out of busy...
View Article
